Guang Li-KY (6431) Corrects Q1 2026 IFRS iXBRL Filing Regarding Investee Information
NQ Score
44/100
AI Summary (NQ-processed)
Guang Li-KY (6431) announced a correction to its first-quarter 2026 IFRS iXBRL filing. The correction specifically addresses the details of its investee companies, including their names, locations, business activities, investment amounts, shareholding status, and recognized investment gains or losses. The company clarified that the original filing did not contain any incorrect amounts or content, but rather an update to the presentation of this specific information was necessary. The corrected information has been re-uploaded to the public information observatory.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the purpose of this announcement?
- A: The announcement is to correct previously filed IFRS iXBRL information for Guang Li-KY's first quarter of 2026.
- Q: What specific information was corrected?
- A: The correction pertains to details of investee companies, such as their names, locations, business types, investment amounts, shareholding percentages, and the recognized investment gains or losses.
- Q: Were there any financial errors in the original filing?
- A: The announcement states that there were no incorrect amounts or content in the original filing; the correction was related to the presentation of information regarding investee companies.
- Q: Which investee companies are mentioned in the corrected filing?
- A: The corrected filing includes information on Novel Idea Co., Ltd. (Mauritius), Taiwan Guang Li Industrial Co., Ltd. (Taiwan), Alliance Capital Investment Management Inc. (British Virgin Islands), Chen Li Biotechnology Co., Ltd. (Taiwan), Suan Li Intelligent Co., Ltd. (Taiwan), Chen Yao Medical Management Consulting Co., Ltd. (Taiwan), and Chen Li International Co., Ltd. (Taiwan).
- Q: What is the company code for Guang Li?
- A: The company code for Guang Li-KY is 6431.